Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep:89:111236.
doi: 10.1016/j.nut.2021.111236. Epub 2021 Mar 7.

Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission

Samir Giuseppe Sukkar  1 , Ludovica Cogorno  2 , Livia Pisciotta  3 , Andrea Pasta  3 , Antonio Vena  4 , Raffaella Gradaschi  3 , Chiara Dentone  4 , Erica Guiddo  3 , Eleonora Martino  3 , Sabrina Beltramini  5 , Lorenzo Maria Donini  6 , Luca Carmisciano  7 , Maria Pia Sormani  7 , Matteo Bassetti  4 ; GECOVID Study Group
Affiliations

Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission

Samir Giuseppe Sukkar et al. Nutrition. 2021 Sep.

Abstract

Objectives: Our primary objective was to explore the effect of a eucaloric ketogenic diet (EKD) on mortality, admission to the intensive care unit, and need for non-invasive ventilation in hospitalized patients with COronaVIrus Disease 19 (COVID-19), in comparison to a eucaloric standard diet. Secondary objectives were verification of the safety and feasibility of the diet and its effects on inflammatory parameters, particularly interleukin-6.

Methods: The study is a retrospective analysis of 34 patients fed with an EKD in comparison to 68 patients fed with a eucaloric standard diet, selected and matched using propensity scores 1:2 to avoid the confounding effect of interfering variables. Our hypothesis was that an EKD would reduce mortality, admission to the intensive care unit, and need for non-invasive ventilation in patients with COVID-19.

Results: The preliminary multivariate analysis showed a statistically significant difference in survival (P = 0.046) and need for the intensive care unit (P = 0.049) for the EKD compared with a eucaloric standard diet. Even considering the EKD start day as a time-dependent variable, the results maintain a positive trend for application of the diet, and it is not possible to reject the null hypothesis (P < 0.05). Interleukin-6 concentrations between t0 and t7 (7 d after the beginning of the diet) in the ketogenic nutrition group show a trend that is almost significant (P = 0.062). The EKD was safe and no adverse events were observed.

Conclusions: These results show a possible therapeutic role of an EKD in the clinical management of COVID-19. Currently, a prospective controlled randomized trial is running to confirm these preliminary data.

Keywords: Aerobic glycolysis; COVID-19; Cytokine storm syndrome; Hyperglycemia; IL-6; Ketogenic diet; SARS-CoV-2; Warburg effect.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Plan of the study.
Fig 2
Fig. 2
Kaplan–Meier estimates (between control and treatment groups) stratified by time-varying start of ketogenic diet for (A) 30-d mortality and (B) need for intensive care unit.
Fig 3
Fig. 3
Variation in interleukin-6 during ketogenic diet versus standard diet.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al. Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93:1449–1458. - PMC - PubMed
    1. Vena A, Giacobbe DR, Di Biagio A, Mikulska M, Taramasso L, De Maria A, GECOVID Study Group Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy. Clin Microbiol Infect. 2020;26:1537–1544. - PMC - PubMed
    1. Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25–32. - PMC - PubMed
    1. Sharma A, Garg A, Rout A, Lavie CJ. Association of obesity with more critical illness in COVID-19. Mayo Clin Proc. 2020;95:2040–2042. - PMC - PubMed
    1. Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clin Proc. 2020;95:1445–1453. - PMC - PubMed